About
Technology
Issues
FAQ
Links
Official Page
REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.